Showing results (431-440 of 592) with videos related to

Sort By:
Pageof 60
Annals of the Rheumatic Diseases|December 7, 2007
Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experienceL C Coates, L S Cawkwell, N W F Ng, et al.
Rheumatology (Oxford, England)|July 11, 2000
How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS)A Young, J Dixey, N Cox, et al.
Rheumatology (Oxford, England)|July 29, 2008
The value of synovial cytokine expression in predicting the clinical response to TNF antagonist therapy (infliximab)M H Buch, R J Reece, M A Quinn, et al.
Annals of the Rheumatic Diseases|March 5, 2002
Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS)A Young, J Dixey, E Kulinskaya, et al.
Annals of the Rheumatic Diseases|January 14, 2005
Pitfalls in scoring MR images of rheumatoid arthritis wrist and metacarpophalangeal jointsF McQueen, M Østergaard, C Peterfy, et al.
Arthritis and Rheumatism|November 30, 2006
Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progressionA K Brown, M A Quinn, Z Karim, et al.
Rheumatology (Oxford, England)|April 12, 2008
Real life experience confirms sustained response to long-term biologics and switching in ankylosing spondylitisL C Coates, L S Cawkwell, N W F Ng, et al.
Arthritis and Rheumatism|January 1, 2008
Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose studyP P Tak, R M Thurlings, C Rossier, et al.
Clinical Radiology|September 22, 2020
Quantitative MRI in myositis patients: comparison with healthy volunteers and radiological visual assessmentM Farrow, J D Biglands, A J Grainger, et al.
Arthritis and Rheumatism|January 5, 2002
Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor alpha transgenic miceG Schett, S Hayer, M Tohidast-Akrad, et al.
Pageof 60